Did you miss CEO Hanna Sjöström’s investor presentation at the Redeye Theme: Medtech & Diagnostics Event 2024? Don’t worry—you can still catch up on all the exciting updates!
In her presentation, CEO Hanna Sjöström highlighted Neola Medical’s significant progress over the past year, including major milestones toward U.S. market approval. The company is now entering a critical clinical validation phase, gearing up for its first pivotal study on preterm born babies in the U.S.—a crucial step toward the FDA application. The presentation also looked ahead, sharing insights into the company’s preparations for an eventual market launch in the U.S. Tune in to learn more!